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Background: The umbilical arterial pH (UApH) in cases of clinically apparent chorioamnionitis (CAM) in which the
infant later develop severe cerebral palsy (CP) has not yet been fully investigated. The objective of this study was to
determine the UApH in CAM cases in which the infant later develop severe CP.
Methods: A review was conducted unti1 April 2014 among 324 infants with CP diagnosed to be caused by antenatal
and/or intrapartum conditions, as determined by the Japan Council for Quality Health Care. Eighty-six infants born at over
34 weeks of gestation with an abnormal FHR pattern during labor were selected. The subjects were divided into
the following two groups: cases with (Group I, n = 19) and those without (Group II, n = 67) clinical CAM. Severe
fetal acidemia was defined as a pH of less than 7.0.
Results: The frequency of severe acidemia in Groups 1 and II was 26.3 and 74.6 %, respectively. In addition, the
frequency of severe acidemia was significantly less in Group I (odds ratio (OR) 0.12, 95 % confidence interval (CI)
0.03–0.53) than in Group II, while the frequency of fetal tachycardia was greater in Group I (OR 7.61, 95 % CI 1.82–31.7)
than in Group II, after adjusting for confounding effects.
Conclusions: The frequency of severe acidemia was lower in the cases of clinical CAM in which the infant later
developed severe cerebral palsy than in the cases without clinical CAM. The relation of fetal tachycardia to CP
with clinical CAM, but not to acidemia, should be reevaluated in such cases.
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Although birth asphyxia may cause cerebral palsy (CP),
it has been demonstrated in controlled population-based
studies that birth asphyxia does not account for most
cases of CP [1]. It has also been reported that there is a
close relationship between CP and clinically apparent
chorioamnionitis (CAM) [2, 3], and CP has been shown
to be induced by the direct effects of cytokines on the
brain, even under conditions of mild hypoxic stress [3].
However, the relationships between infection/inflamma-
tion and the onset of CP remain unclear.
Severe/pathological fetal acidemia is defined as an um-
bilical arterial pH (UApH) of less than 7.0 and base* Correspondence: yoshiom2979@gmail.com
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unless otherwise stated.deficit ≧12 mmol/l [4]. This condition is an objective
measurement of the level of intrapartum hypoxia-
ischemia and correlates with the occurrence of hypoxic
ischemic encephalopathy [4]. The Japan obstetric com-
pensation system for CP was established by the Japan
Council for Quality Health Care (JCQHC) to compen-
sate for CP resulting from intrapartum events and im-
prove perinatal care. Using this system, we recently
reported that placental abruption is the factor most as-
sociated with a low UApH and that even among infants
with severe CP, over 10 % of all patients exhibited a
non-acidemic status at birth [5]. In addition, there is a
hierarchy, in which the lowest UApH is associated with
placental abruption followed by an abnormal FHR pat-
tern and an abnormal FHR pattern with CAM [5].
The present study was therefore performed to deter-
mine the UApH in clinically apparent CAM cases inl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Causative factors in this study subjects
Causative factors Numbers
Antenatal 38 (11.7 %)




Maternal hypoxic event 8
Fetal exsanguination 8
Clinical CAM (Group I ) 19
Non clinical CAM (Group II) 67
Perinatal 8 (2.5 %)
Fetal central nervous system or systemic infection 8




Abbreviations, CAM: chorioamnionitis, suspected CAM: suspected cases which
did not fulfil the criteria of clinical CAM
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compensation system for CP.
Methods
This study was approved by the Ethics Committee of the
International University of Health and Welfare Hospital,
Tochigi, Japan.
The Japan obstetric compensation system for CP was
launched on January l, 2009 to provide rapid monetary
compensation for cases of CP [6] certified as first- or
second-degree in severity according to the criteria of the
Japanese Social Welfare System [7] in infants with a birth
weight of over 2000 g and/or pregnancy length of over
33 weeks. In each case, a professional committee of the
JCQHC consisting of physicians, midwives, lawyers and
citizens carefully investigates the causative factors for CP
and publishes a brief summary of the case with the cause
of CP, with privacy protection, on their website [5, 8, 9].
A review was conducted unti1 April 2014 among 324 in-
fants with CP diagnosed to be caused by antenatal and/or
intrapartum conditions as determined by the JCQHC. A11
324 infants were born during or after January 2009.
Clinical chorioamnionitis (CAM) was defined as a mater-
nal temperature of ≧ 38 °C and at least one of the following
four criteria: maternal tachycardia of ≧ 100 bpm, uterine
tenderness, white blood cell count of ≧ 15,000/mm3 or foul
smelling vaginal discharge [10].
The FHR pattern observed two hours before delivery
was defined as abnormal if one of the following patterns
was detected: recurrent late decelerations, minimal or
absent variability lasting for 40–60 min, severe variable
decelerations, prolonged decelerations, tachycardia or
bradycardia [11, 12]. Severe variable deceleration was
defined as the lowest point, which was less than 70 bpm,
and it continued for more than 30 sec, or the lowest
point, which was more than 70 bpm and less than
80 bpm, and it continued for more than 60 sec [13].
These patterns were also used to assess the preterm fe-
tuses. Bradycardia was defined as a baseline FHR of less
than 100 bpm (>3 min) [12].
The causative factors for CP in 324 cases were classified
according to the report by MacLennan (International
Consensus Criteria) with modifications [12–15]. In 38
cases, the timing of the factor was thought to be an ante-
natal. Sentinel hypoxic event occurring immediately before
or during labor were as follows: placental abruption
(n = 87), cord prolapse (n = 16), a ruptured uterus (n = 15),
maternal hypoxic events including amniotic fluid embolism
(n = 8), and fetal exsanguinations due to vasa previa or feto-
maternal hemorrhage (n = 8). Other factor suggesting that
CP was caused by an event other than acute intrapartum
hypoxia (perinatal hypoxia) was central nervous system or
systemic infection except for clinical CAM (n = 8). The
miscellaneous cases were 58 cases, including suspectedcases which did not fulfil the criteria of clinical CAM (54
cases) or unknown cause (4 cases). The remaining 86 cases
were divided into two groups: cases with (Group I, n = 19)
and cases without (Group II, n = 67) clinical CAM, in order
to clarify the characteristics of the cases of clinical CAM in
which the infant later developed CP (Table 1).
Severe/pathological fetal acidemia was defined as UApH
of less than 7.0 and base deficit ≧12 mmol/l [4]. The distri-
bution of UApH was graded as follows: less than 7.0
(severe/pathological acidemia) and more than 7.00.
The results are expressed as the mean ± standard devi-
ation (SD), range (minimum to maximum value) or fre-
quency (percent). The statistical analysis was conducted
using the chi-square test, Fisher’s exact probability test
or Mann-Whitney test, as appropriate. P values of less
than 0.05 were considered to be significant. The odds ra-
tios (ORs), adjusted ORs, and 95 % confidence intervals
(CIs) were calculated to estimate the relative risk be-
tween Groups I and II. The variables were compared in
both univariate and multivariate analyses. Logistic re-
gression models were used to assess confounding effects.
Our selection of the risk factors for inclusion in the re-
gression model was based on the clinically important
factors as well as the results of a univariate analysis.
Results
Clinical background factors in Group I
The characteristics of the 86 selected cases are summa-
rized as follows: gestational age = 39.0 ± 1.5 weeks, birth
weight = 2918.7 ± 499.1 g and UApH = 6.88 ± 0.18.
Table 2 shows the clinical characteristics of Group I.
Rupture of the membranes before the onset of labor was
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in 15 cases (78.9 %) and augmentation was performed in
nine cases (47.4 %). The results of the detailed analyses
of the FHR patterns are reported in Tables 3 and 4.Comparison of the clinical characteristics of the two
groups and frequency of an abnormal FHR pattern in the
two groups
Table 3 shows a comparison of the clinical characteris-
tics of the two groups. According to the univariate ana-
lysis, the frequency of severe acidemia (Group I, 26.3 %
and Group II, 74.6 %) and fetal tachycardia (Group I,
57.9 % and Group II, 14.9 %) was significantly different
between the two groups. There were no significant dif-
ferences between the two groups in terms of the other
factors.
For factors considered to be possible factors, a further
analysis was performed using a logistic regression ana-
lysis (Table 4). The results showed that the frequency of
severe acidemia was significantly lower in Group I (OR
0.12, 95 % CI 0.03–0.53) than in Group II, while the fre-
quency of tachycardia was greater in Group I (OR 7.61,
95 % CI 1.82–31.7) than in Group II, after adjusting for
confounding effects.Table 2 Clinical characteristics of Group I (with Chorioamnionitis)
No GW BW
[g]
ROM before labor Mode of delivery AS 1′/5′ UmApH
1 35 2750 + V 4/6 7.2
2 36 2552 + V 0/0 6.8
3 38 2336 + C 2/2 7.1
4 38 2386 − V 1/3 7.1
5 39 2158 + C 1/2 7.1
6 39 2540 + I 1/1 7.0
7 39 2835 + I 2/2 7.0
8 39 2870 + I 5/6 7.3
9 39 2980 − C 1/4 6.9
10 39 3284 − V 3/5 7.1
11 39 3364 − C 1/5 7.0
12 39 3450 + V 1/2 6.8
13 39 3860 + V 1/4 7.1
14 40 3015 − I 3/6 6.8
15 40 3048 + C 1/3 6.8
16 40 3282 − V 1/3 7.1
17 40 3436 + I 3/5 7.1
18 41 2743 − V 6/6 7.1
19 41 3110 − C 1/4 7.0
Abbreviations, GW: gestational weeks at delivery, BW: birth weight, AS1′/5′: Apgar s
membranes Antibio/Augment: antibiotics or augmentation, FHR: fetal heart rate, PD
late deceleration, SVD: severe variable deceleration, Tachy: tachycardia, V: vaginal, I:Discussion
The present study investigated the UApH values in cases
of clinically apparent CAM in which the infant later de-
veloped severe CP. Consequently, the frequency of se-
vere fetal acidemia was lower in these cases than in
those without CAM. In addition, tachycardia was more
frequent in the cases of clinical CAM, whereas the fre-
quency of other abnormal FHR patterns did not differ
statistically between the two groups.
Several mechanisms have been proposed to explain
the association between clinical CAM and CP, includ-
ing an inflammatory cytokine response, placental inflam-
mation leading to impaired placental perfusion and gas
exchange and intrauterine infection with bacteremia
resulting in the direct involvement of the brain or
fever associated with the infection itself exacerbating
the primary insult to the brain [16]. Whether the pres-
ence of infection/inflammation, such as that associ-
ated with CAM, confers an additional risk for CP in
term infants delivered in the presence of fetal acidosis
has not been thoroughly studied. A single severe ex-
posure, such as uterine rupture or massive abruption,
may be sufficient to cause CP; however, much more
often, it is not a single cause, but rather multiple con-
current risk factors, that precede the onset of CP. In/ base deficit Inter-vention Nonreassuring FHR pattern
Antibio/ Augment PD Mi/ AbVb RLD SVD Tachy
01/9.0 +/− − − − + −
76/23 +/− − + − + +
13/14.5 +/+ + − − − −
04/9.2 +/− + − + − +
66/12.6 +/+ + − − − −
16/13 +/+ + − − − −
90/NA +/− − − − − +
50/6.8 +/+ + − − − −
43/17.7 +/− − − + − +
64/15.6 −/− − − − − +
80/19 +/− + − + − +
19/22 −/− − − + − −
91/11 −/+ + + − − +
37/24 +/− + − + − +
49/21.1 +/− + − − − −
00/16 +/+ + + − − −
94/6 +/+ + + + − +
379.6 −/+ − − + − +
67/NA +/+ + − − − +
core at 1 /5 min, UmApH: blood pH of umbilical artery, ROM: from rupture of
: prolonged deceleration, Mi/AbVb: minimal or absent viability, RLD: recurrent
instrumental, C: cesarean, +: present, −: absent
Table 3 Comparison of the clinical characteristics of the two groups
Group 1 (with CAM) Group 2 (without CAM)
n = 19 n = 67 p
Gestational age at delivery 38.9 ± 1.5 39.0 ± 1.5 0.801
Birth weight (g) 2947.3 ± 440.9 2910.6 ± 517.2 0.759
pH less than 7.0 (severe acidemia) 5 (26.3 %) 50 (74.6 %) <0.0001
Base deficit ≧12 mmol/l 11 (11/17, 64.7 %) 57 (57/62, 91.9 %) 0.018
Fetal growth restriction 4 (21.1 %) 14 (20.9 %) 0.76
Instrumental vaginal delivery 5 (26.3 %) 30 (44.8 %) 0.236
Cesarean section 6 (31.6 %) 18 (26.9 %) 0.890
Prolonged deceleration 12 (63.2 %) 58 (86.6 %) 0.048
Minimal or absent variability 4 (21.1 %) 30 (44.8 %) 0.104
Recurrent late deceleration 7 (36.8 %) 29 (43.3 %) 0.818
Severe variable deceleration 2 (10.5 %) 23 (34.3 %) 0.0920
Tachycardia 11 (57.9 %) 10 (14.9 %) <0.0001
Abbreviations, CAM: chorioamnionitis
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was significantly lower among the cases of clinical
CAM with an abnormal FHR pattern than in those
without clinical CAM. This finding indicates that
brain injury may occur following a low level of hyp-
oxic stress in the presence of clinical CAM. Garnier
et al. [17] showed that intrauterine exposure to infec-
tion severely altered fetal cardiovascular function,
resulting in dysregulation of cerebral blood flow and
subsequent hypoxic-ischemic brain injury. In chronic-
ally instrumented fetal sheep, intravenous injection of
lipopolysaccharide (LPS) decreased placental blood
flow, whereas blood flow to the peripheral organ in-
creased. The decrease in placental blood flow was ac-
companied by sustained hypotension, hypoxemia, and
mixed acidosis causing dysregulation of cerebral blood
flow. Because the simultaneous the change of FHR
pattern was not examined in detail, further study is
needed to show the relationship between the change
of FHR pattern and the degree of infection.
In this study, we were unable to clarify characteristic
FHR patterns associated with clinical CAM in which
the infant later developed CP, as discussed by other re-
searchers [18]. For example, it has been postulated thatTable 4 Results of the univariate and multivariate analysis
Univ
Potential factors OR (9
pH less than 7.0 (severe acidemia) 0.12
Base deficit ≧12 mmol/l 0.70
Prolonged deceleration 0.27
Severe variable deceleration 0.24
Tachycardia 7.84
Abbreviations, OR: odds ratio, CI: confidence intervalincreased cytokines in such cases induce ischemia of
the umbilical or uterine vessels, subsequently resulting
in variable or late decelerations, in which the fetus may
become hypoxic and acidotic.
In isolation, tachycardia is poorly predictive of fetal
hypoxemia or acidemia, unless accompanied by minimal
or absent FHR variability, recurrent late/variable deceler-
ations or both [11]. On the other hand, Sameshima et al.
[19] reported that the development of CP in pregnancies
with intrauterine bacterial infection is associated with
tachycardia, but not FHR deceleration patterns or acide-
mia, suggesting the presence of a different pathophysi-
ology in these cases from that observed in the setting of
acute hypoxia-ischemia.
In Japan, standardized FHR pattern management has
recently been implemented [13]. Importantly, it has
been reported that the degree of level has been ranked
up when there are the presence of background compli-
cations, such as placental abnormalities or intrauterine
fetal growth restriction. Clinical CAM should be in-
cluded as such an obstetrical complication.
Our data are not derived from a nationwide population-
based cohort, as an essential information was masked for
personal protection. Nevertheless, the peer review systemariate analysis Multivariate analysis
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argued that our results are influenced by bias due to the
small sample size; however, we consider this to be unlikely
given the low-frequency nature of the cohort.
Further studies are needed to confirm the relationship
between an abnormal intrapartum FHR pattern and the
presence of clinical CAM by collecting data in such cases
prospectively, including those in which the infant later
develops CP.
Conclusions
The frequency of severe acidemia was lower in the cases
of clinical CAM in which the infant later developed se-
vere cerebral palsy than in the cases without clinical
CAM. The relation of fetal tachycardia to CP with clin-
ical CAM, but not to acidemia, should be reevaluated in
such cases.
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